Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7Sarcoma 1Plasma cell 1Gynecologic 1Dermatologic 1

Conditions

Multiple Myeloma 44Lymphoma 13Ovarian Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Melanoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Plasmacytoma 1Pancreatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

fludarabine phosphate 4Cyclophosphamide 4Antilymphocyte Serum 4Mycophenolic Acid 3Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Filgrastim 2Cyclosporine 2Busulfan 2thymoglobulin 1sargramostim 1orantinib 1interferon-alfa-1b 1fludarabine 1cc-486 1carfilzomib 1aldesleukin 1Whole-Body Irradiation 1Voriconazole 1Stem Cell Transplantation 1Social Determinants of Health 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Interleukin-12 Subunit p35 1Interferons 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Magnetic Resonance Spectroscopy × Plasma cell × Clear all
NCT00123773 2016-02-26

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

AHS Cancer Control Alberta

Phase 2 Completed
1,075 enrolled
GenitourinaryGynecologicPlasma cellSarcoma

Kidney Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡